These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 9834259

  • 1. Ranitidine controls nocturnal gastric acid breakthrough on omeprazole: a controlled study in normal subjects.
    Peghini PL, Katz PO, Castell DO.
    Gastroenterology; 1998 Dec; 115(6):1335-9. PubMed ID: 9834259
    [Abstract] [Full Text] [Related]

  • 2. Bedtime ranitidine does not eliminate the need for a second daily dose of omeprazole to suppress nocturnal gastric pH.
    Khoury RM, Katz PO, Hammod R, Castell DO.
    Aliment Pharmacol Ther; 1999 May; 13(5):675-8. PubMed ID: 10233192
    [Abstract] [Full Text] [Related]

  • 3. Control of nocturnal gastric acidity: a role for low dose bedtime ranitidine to supplement daily omeprazole.
    Robinson M, Rodriguez-Stanley S, Ciociola AA, Filinto J, Zubaidi S, Miner PB, Gardner JD.
    Dig Dis Sci; 2002 Feb; 47(2):265-73. PubMed ID: 11855540
    [Abstract] [Full Text] [Related]

  • 4. Bedtime H2 blockers improve nocturnal gastric acid control in GERD patients on proton pump inhibitors.
    Xue S, Katz PO, Banerjee P, Tutuian R, Castell DO.
    Aliment Pharmacol Ther; 2001 Sep; 15(9):1351-6. PubMed ID: 11552905
    [Abstract] [Full Text] [Related]

  • 5. The efficacy of omeprazole twice daily with supplemental H2 blockade at bedtime in the suppression of nocturnal oesophageal and gastric acidity.
    Orr WC, Harnish MJ.
    Aliment Pharmacol Ther; 2003 Jun 15; 17(12):1553-8. PubMed ID: 12823159
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Comparison of the effects of immediate-release omeprazole powder for oral suspension and pantoprazole delayed-release tablets on nocturnal acid breakthrough in patients with symptomatic gastro-oesophageal reflux disease.
    Castell D, Bagin R, Goldlust B, Major J, Hepburn B.
    Aliment Pharmacol Ther; 2005 Jun 15; 21(12):1467-74. PubMed ID: 15948814
    [Abstract] [Full Text] [Related]

  • 10. Gastric acidity and acid breakthrough with twice-daily omeprazole or lansoprazole.
    Katz PO, Hatlebakk JG, Castell DO.
    Aliment Pharmacol Ther; 2000 Jun 15; 14(6):709-14. PubMed ID: 10848653
    [Abstract] [Full Text] [Related]

  • 11. Over-the-counter H(2)-receptor antagonists do not compromise intragastric pH control with proton pump inhibitors.
    Tutuian R, Katz PO, Ahmed F, Korn S, Castell DO.
    Aliment Pharmacol Ther; 2002 Mar 15; 16(3):473-7. PubMed ID: 11876700
    [Abstract] [Full Text] [Related]

  • 12. Nocturnal acid breakthrough in children with reflux esophagitis taking proton pump inhibitors.
    Pfefferkorn MD, Croffie JM, Gupta SK, Molleston JP, Eckert GJ, Corkins MR, Fitzgerald JF.
    J Pediatr Gastroenterol Nutr; 2006 Feb 15; 42(2):160-5. PubMed ID: 16456408
    [Abstract] [Full Text] [Related]

  • 13. Twenty-four-hour intragastric acidity: 300 mg ranitidine b.d., 20 mg omeprazole o.m., 40 mg omeprazole o.m. vs. placebo.
    Houben GM, Hooi J, Hameeteman W, Stockbrügger RW.
    Aliment Pharmacol Ther; 1995 Dec 15; 9(6):649-54. PubMed ID: 8824652
    [Abstract] [Full Text] [Related]

  • 14. The effect of orally administered ranitidine and once-daily or twice-daily orally administered omeprazole on intragastric pH in cats.
    Šutalo S, Ruetten M, Hartnack S, Reusch CE, Kook PH.
    J Vet Intern Med; 2015 Dec 15; 29(3):840-6. PubMed ID: 25966746
    [Abstract] [Full Text] [Related]

  • 15. Combination drug therapy for gastroesophageal reflux disease.
    Cross LB, Justice LN.
    Ann Pharmacother; 2002 May 15; 36(5):912-6. PubMed ID: 11978171
    [Abstract] [Full Text] [Related]

  • 16. Intragastric pH after oral administration of single doses of ranitidine effervescent tablets, omeprazole capsules and famotidine fast-dissolving tablets to fasting healthy volunteers.
    Hedenström H, Alm C, Kraft M, Grahnén A.
    Aliment Pharmacol Ther; 1997 Dec 15; 11(6):1137-41. PubMed ID: 9663842
    [Abstract] [Full Text] [Related]

  • 17. Comparison of the effects of immediate-release omeprazole oral suspension, delayed-release lansoprazole capsules and delayed-release esomeprazole capsules on nocturnal gastric acidity after bedtime dosing in patients with night-time GERD symptoms.
    Katz PO, Koch FK, Ballard ED, Bagin RG, Gautille TC, Checani GC, Hogan DL, Pratha VS.
    Aliment Pharmacol Ther; 2007 Jan 15; 25(2):197-205. PubMed ID: 17229243
    [Abstract] [Full Text] [Related]

  • 18. Effect of curing Helicobacter pylori infection on intragastric acidity during treatment with ranitidine in patients with duodenal ulcer.
    Labenz J, Tillenburg B, Peitz U, Verdú E, Stolte M, Börsch G, Blum AL.
    Gut; 1997 Jul 15; 41(1):33-6. PubMed ID: 9274468
    [Abstract] [Full Text] [Related]

  • 19. Long-term effect of H2RA therapy on nocturnal gastric acid breakthrough.
    Fackler WK, Ours TM, Vaezi MF, Richter JE.
    Gastroenterology; 2002 Mar 15; 122(3):625-32. PubMed ID: 11874994
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.